Activation and Conjugation of Soluble Polysaccharides using 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP).


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
14 06 2021
Historique:
entrez: 28 6 2021
pubmed: 29 6 2021
medline: 16 10 2021
Statut: epublish

Résumé

Conjugate vaccines are remarkable advances in vaccinology. For the preparation of polysaccharide conjugate vaccines, the polysaccharides can be conveniently functionalized and linked to vaccine carrier proteins using 1-cyano-4-dimethylaminopyridine tetrafluoroborate (CDAP), an easy-to-handle cyanylating reagent. CDAP activates polysaccharides by reacting with carbohydrate hydroxyl groups at pH 7-9. The stability and reactivity of CDAP are highly pH-dependent. The pH of the reaction also decreases during activation due to the hydrolysis of CDAP, which makes good pH control the key to reproducible activation. The original CDAP activation protocol was performed at room temperature in unbuffered pH 9 solutions. Due to the rapid reaction under this condition (<3 min) and the accompanying fast pH drop from the rapid CDAP hydrolysis, it was challenging to quickly adjust and maintain the target reaction pH in the short time frame. The improved protocol described here is performed at 0 °C, which slows CDAP hydrolysis and extends the activation time from 3 min to ~15 min. Dimethylaminopyridine (DMAP) was also used as a buffer to pre-adjust the polysaccharide solution to the target activation pH before adding the CDAP reagent. The longer reaction time, coupled with the slower CDAP hydrolysis and the use of DMAP buffer, makes it easier to maintain the activation pH for the entire duration of the activation process. The improved protocol makes the activation process less frenetic, more reproducible, and more amenable to scaling up.

Identifiants

pubmed: 34180904
doi: 10.3791/62597
doi:

Substances chimiques

Indicators and Reagents 0
Polysaccharides 0
Vaccines, Conjugate 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Andrew Lees (A)

Fina Biosolutions LLC; alees@finabio.com.

James Zhou (J)

Fina Biosolutions LLC.

Articles similaires

Animals Flax Chickens Dietary Supplements Endo-1,4-beta Xylanases
Substrate Specificity Peptides Catalysis Hydrolysis Protein Conformation
Humans Streptococcus pneumoniae Pneumococcal Infections Serogroup Asia, Southeastern
Humans Male Netherton Syndrome Female Pneumococcal Vaccines

Classifications MeSH